HCPLive

Top Medical News Today

Urban, Rural Living Not a Determinant of Asthma in Blacks
Urban, Rural Living Not a Determinant of Asthma in Blacks
A comparison of urban and rural black youths has shown no difference in asthma prevalence rates, thus highlighting poverty’s role in the disease’s development.
Q&A With Gerald Smetana, MD, from Beth Israel Deaconess Medical Center: Discussing Rivaroxaban's Newest Approvals in Primary Care
Rivaroxaban, also known as Xarelto has been on the market for many years but was recently approved for use in patients with DVT and pulmonary embolism.
New Transplant Drug Reduces Rejection Risk
A 7-year followup study of a drug approved in 2011 shows it has better results than cyclosporine in kidney patients. But it comes with a warning.
Q&A With Gerald Smetana, MD, from Beth Israel Deaconess Medical Center: Weighing Benefits of Vorapaxar for Patients
With primary care physicians treating such a broad spectrum of conditions they also have a number of medications they can prescribe to help their patients. While some of these are more beneficial than others it is important to consider which might be more effective for patients.
Bacteria Passenger Identified, New Antibiotics Could Be Next
New antibiotics may be on the horizon against disease-causing bacteria due to a promising study from Australian researchers.
Q&A With Akinlolu Ojo, MD, From the University of Michigan: New Medications for Hyperkalemia Patients
Hyperkalemia can be a significant diagnosis for patients and finding the right treatment can have a great impact on their quality of life. New medications could help in their daily care.
Q&A With Akinlolu Ojo, MD, From the University of Michigan: New Monitoring Methods for Hypertension Patients
Hypertension is a common diagnosis in patients and can often require patients to visit their doctors on a regular basis. A new approach to treatment could mean fewer trips for patients while providing a high level of care at the same time.

Most Popular

Recent Published Journal

$vacMongoViewPlus$ $vAR$